- April 2021
- Venture capital watch: Interview with Alessandra Lomonaco (Huky)
- March 2021
- Venture capital watch: Interview with Marco Di Miceli (Sequitur Capital)
- Risk prevention–based regulation: The importance of compliance programs in the context of the New Insolvency Code
- What innovators say: Interviews with the main stakeholders in the innovation scene
- February 2021
- Foreign investment control regulations: extension of COVID-19–related rules and new list and definition of strategic assets with a brief focus on the health industry
- New recommendation issued by the Notarial Council of Milan on shareholders’ agreements and transfer of shares
- November 2020
- Management duties and possible reporting to the Court for breach pursuant to section 2409 of the Italian Civil Code
- Public companies: Limits to derogation from the provisions of the Italian Civil Code
- October 2020
- Commercial leases in the COVID-19 pandemic: An update on the latest court trends on negotiating opportunities
- Foreign investment control in the life science sector: the scope of the Italian Government’s powers also in the context of the current COVID-19 pandemic
- Venture Capital Watch: Interview with Lorenzo Pisoni (PCUP)
- September 2020
- Life Sciences M&A trends: earnout clauses, general outlook, and a few drafting tips
- The Regional Administrative Court of Lazio on transparency obligations regarding ownership structures of a newspaper publishing company
- The latest on startup regulations in the COVID-19 era
- M&A tips from the revised DOJ guidance on compliance programs
- Business judgment rule: directors may be held liable for disproportionate organizational decisions
- July 2020
- The further expansion of the Italian foreign investment control to protect employment levels and national productivity
- Decreto Rilancio: an overview of the most important measures for startups
- Venture Capital Watch: Interview with Roberta Gilardi (G2 Startups) and Fabrizio Conicella (ZCube - Zambon and OpenZone) on how Covid-19 is affecting the Venture Capital
- June 2020
- Acquisitions of companies involved in the medical devices business fall under the Italian foreign investment control